MedPath

Study With Medical Nutrition Product PTM202 in Pediatric Diarrhea

Not Applicable
Completed
Conditions
Acute Diarrhea
Interventions
Other: PTM202
Other: Placebo
Registration Number
NCT01814202
Lead Sponsor
PanTheryx, Inc.
Brief Summary

The purpose of this study is to determine whether a medical nutrition product, PTM202, along with standard of care, enhances recovery and reduces diarrhea morbidity in young children

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
68
Inclusion Criteria
  • males or females between 6 months and 5 years of age
  • acute diarrhea (<48 hours) without interfering co-morbidities
  • guardian willing to have child admitted to hospital as an inpatient for 96 hours and to return to the clinic with the child on Day 7 for a final evaluation
  • Guardian is willing and able to report to the Investigator information on stool frequency, stool consistency and food and water intakes during the follow up phase.
  • Written informed consent must be obtained prior to admission to this study.
  • The subject has a physical examination that reveals no clinically significant abnormalities other than those expected for subjects with acute infectious diarrhea.
Exclusion Criteria
  • Suspected or confirmed cholera
  • Suspected dysentery
  • Symptom duration >48 hours at screening
  • Vomiting severity that is like to make administration and retention of test article impossible
  • Severe malnutrition (defined as weight for height of less than -3 SD below median, per WHO Standards (6).
  • Child already receiving antibiotics or anti-motility drugs for this diarrhea episode prior to screening.
  • History of hypersensitivity or allergy to milk or egg

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PTM202PTM202PTM202 is a medical nutrition product
PlaceboPlaceboThe placebo is a placebo for PTM202, a food product that can not be distinguished from PTM202 by appearance, taste or odor
Primary Outcome Measures
NameTimeMethod
diarrhea duration7 days
Secondary Outcome Measures
NameTimeMethod
stool frequency7 days
stool consistency7 days
food intake7 days

Trial Locations

Locations (1)

International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b)

🇧🇩

Dhaka, Bangladesh

© Copyright 2025. All Rights Reserved by MedPath